AROA Biosurgery Completes Randomised Controlled Trial for SymphonyTM; Preliminary Read-Out indicates Primary Endpoint Met
AUCKLAND, New Zealand, March 29, 2026 /PRNewswire/ -- Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint.
AB
aroa biosurgery
via Manchestertimes - Corroborated by 9 others
Updated 1h ago
Source Verification
Corroboration Score: 10This story was independently reported by 10 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Is APA Corporation (APA) A Good Stock To Buy Now?
Next
Some of the best Lego deals I've seen are at Amazon right now — Star Wars, Technic, and Botanicals sets from $13.49
Related Articles
HealthTracker - The Field Trip - Review: A Parent’s Worst Nightmare
Spoilertv-13h ago-1 sources
Health23 Women Share How Their Partner Changed After They Became A Mom
BuzzFeed-14h ago-1 sources
HealthPsychology says the reason some people become wiser as they age while others become more rigid has nothing to do with intelligence. It depends on whether they ever learned to sit with discomfort
Silicon Canals-14h ago-1 sources